Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results

Go back to Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results
JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) Delayed: 245.13 +1.42 (0.58%)
Previous Close $243.71    52 Week High $160.00 
Open $244.00    52 Week Low $95.80 
Day High $248.07    P/E 45.56 
Day Low $243.81    EPS $5.38 
Volume 34,616